The POU3F4 gene plays a critical role in the development of the inner ear, and mutations in this gene can lead to a form of hearing loss known as Deafness X-linked type 2. This condition is characterized by progressive hearing loss that mainly affects males, due to its X-linked inheritance pattern. To diagnose this specific type of genetic hearing loss, a genetic test targeting the POU3F4 gene can be conducted.
DNA Labs UAE offers a specialized genetic test for the POU3F4 gene to identify mutations associated with Deafness X-linked type 2. This test is crucial for families with a history of X-linked hearing loss, providing them with valuable information for early intervention and management strategies. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the POU3F4 gene.
The cost of the POU3F4 gene deafness X-linked type 2 genetic test at DNA Labs UAE is 4400 AED. This price includes the cost of sample collection, genetic analysis, and a comprehensive report that explains the test results. It is a valuable investment for affected families seeking clarity on their genetic status and guidance on managing the condition.
The SMPX Gene Deafness X-Linked Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SMPX gene, which are associated with X-linked type 4 deafness. This condition is a rare form of genetic hearing loss passed down through the X chromosome, affecting males more severely than females. The test is crucial for early detection and management of the condition, enabling healthcare providers to offer appropriate interventions and support to affected individuals and their families. Priced at 4400 AED, this test is a valuable tool for those with a family history of X-linked deafness, offering insights into genetic predispositions and facilitating informed decision-making regarding healthcare and lifestyle adjustments.
The AIFM1 Gene Deafness X-Linked Type 5 Genetic Test is a specialized diagnostic tool designed to identify mutations in the AIFM1 gene, which are linked to a rare form of hereditary hearing loss known as Deafness X-Linked Type 5. This condition is characterized by progressive sensorineural hearing impairment that predominantly affects males, due to its X-linked mode of inheritance. The test is crucial for families with a history of this condition, as it can provide definitive diagnosis, inform about the risk of transmission to future generations, and guide decisions on management and treatment.
Conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test involves analyzing the patient's DNA sample, typically obtained through a blood draw or a cheek swab, to detect any pathogenic variants in the AIFM1 gene. The process is comprehensive, employing advanced genetic sequencing technologies to ensure high accuracy and reliability of results.
The cost of the AIFM1 Gene Deafness X-Linked Type 5 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the intricate nature of the genetic analysis and the specialized expertise required to interpret the results. For individuals and families facing the possibility of X-linked deafness, this test represents a critical step towards understanding their genetic status and making informed health and lifestyle decisions.
The PJVK Gene Deafness Autosomal Recessive Type 59 Genetic Test is a specialized diagnostic tool used to identify mutations in the PJVK gene, which are linked to Autosomal Recessive Deafness 59 (DFNB59). This condition is a form of genetic hearing loss where both copies of the PJVK gene in an individual have mutations. The test is crucial for early detection, allowing for timely intervention and management strategies to be implemented for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the PJVK gene to detect any abnormalities that may contribute to hearing loss. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology utilized in identifying the genetic mutations responsible for this condition.
By opting for this genetic test, individuals at risk or families with a history of hearing loss can gain valuable insights into their genetic makeup, enabling them to make informed health and lifestyle decisions. DNA Labs UAE ensures accuracy and confidentiality in the testing process, offering support and guidance throughout the testing and post-analysis phases.
The TMIE Gene Deafness Autosomal Recessive Type 63 Genetic Test is a specialized diagnostic tool designed to identify mutations in the TMIE gene, which are linked to a specific form of hereditary hearing loss known as Autosomal Recessive Deafness Type 63 (DFNB63). This condition is characterized by a genetic predisposition to early-onset sensorineural hearing loss, where the affected individuals inherit two copies of the mutated gene, one from each parent. The test is particularly vital for families with a history of this condition, as it aids in early diagnosis, which is crucial for the management and treatment of the hearing impairment.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test ensures accuracy and reliability in results. The cost of the TMIE Gene Deafness Autosomal Recessive Type 63 Genetic Test is set at 4400 AED, reflecting the comprehensive analysis and the advanced technology employed to detect the genetic mutations accurately. Opting for this test at DNA Labs UAE offers individuals and families peace of mind through early detection, enabling them to make informed decisions regarding their health and well-being.
The SLC26A5 gene, also known as the prestin gene, is crucial for normal hearing function. Mutations in this gene can lead to Deafness Autosomal Recessive Type 61 (DFNB61), a form of hereditary hearing loss. This condition is characterized by the absence or severe reduction of hearing from birth. It is passed down through families in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this specific type of genetic hearing loss, a genetic test targeting the SLC26A5 gene can be conducted. This test involves analyzing the DNA to identify mutations in the SLC26A5 gene that are known to cause DFNB61. It is a crucial step for families with a history of hearing loss, as it can confirm the diagnosis, provide information about the inheritance pattern, and inform decisions about family planning.
In the United Arab Emirates, this specific genetic test is available at DNA Labs UAE. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced technology and staffed by professionals skilled in genetic testing and counseling. The test is performed with a simple blood sample or cheek swab from the individual. Results from the test can help in the early detection of hearing loss, enabling timely intervention and management strategies to improve the quality of life for those affected by DFNB61.
The LRTOMT Gene Deafness Autosomal Recessive Type 63 Genetic Test is a specialized diagnostic tool designed to identify mutations in the LRTOMT gene, which are linked to a specific form of hereditary hearing loss known as Autosomal Recessive Deafness Type 63. This condition is characterized by the inheritance of two copies of the mutated gene, one from each parent, leading to a high risk of developing hearing impairment from birth or early childhood. The test involves analyzing the patient's DNA to pinpoint any alterations in the LRTOMT gene that are associated with this type of hearing loss.
Offered by DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test is priced at 4400 AED. DNA Labs UAE employs state-of-the-art technology and methodologies to ensure accurate and reliable results, providing essential information for the diagnosis and management of genetic hearing loss. By identifying the genetic basis of deafness in affected individuals, this test plays a crucial role in guiding treatment decisions, including the consideration of hearing aids, cochlear implants, and other interventions aimed at improving quality of life for those with Autosomal Recessive Deafness Type 63.
The RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the RDX gene, which are linked to a specific type of hereditary hearing loss known as Autosomal Recessive Deafness Type 24 (DFNB24). This form of hearing impairment is passed down through families in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The process involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities associated with the RDX gene.
The cost of the RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test at DNA Labs UAE is set at 4400 AED. This price includes the comprehensive analysis required to accurately identify the presence of the specific gene mutations linked to this type of deafness. For individuals with a family history of hearing loss or parents planning to have children and wanting to assess their genetic risk, this test provides crucial information that can help in managing or mitigating the impact of this condition.
By pinpointing the genetic cause of hearing loss, the test not only facilitates early intervention and treatment options but also offers valuable insights for family planning and genetic counseling, aiding families in understanding their genetic makeup and its implications for future generations.
The TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the TRIOBP gene, which are linked to a specific form of genetic hearing loss known as Autosomal Recessive Deafness Type 28 (DFNB28). This condition is characterized by the inheritance of two copies of the mutated gene, one from each parent, leading to early-onset sensorineural hearing loss, which affects the inner ear or nerve pathways to the brain.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to search for the specific genetic alterations within the TRIOBP gene that are known to cause this type of hearing loss. It is particularly recommended for individuals with a family history of hearing impairment or parents planning to have children who may be at risk of inheriting the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers a comprehensive approach to diagnosing this rare form of deafness. The cost of the test is set at 4400 AED, reflecting the intricate laboratory work and expert analysis required to accurately identify the genetic mutation responsible for the condition. This test not only aids in the diagnosis but also helps in the management and planning for the needs of individuals affected by Autosomal Recessive Deafness Type 28, providing essential information for families and healthcare providers.
The CLDN14 gene plays a crucial role in the proper functioning of the inner ear, and mutations in this gene can lead to deafness autosomal recessive type 29 (DFNB29), a condition characterized by early-onset, non-syndromic sensorineural hearing loss. This form of hearing loss is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this specific genetic cause of deafness, a genetic test focusing on the CLDN14 gene can be conducted. DNA Labs UAE offers this specialized test, providing a valuable tool for families seeking answers about their genetic predisposition to hearing loss. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for mutations in the CLDN14 gene.
The cost of the CLDN14 gene deafness autosomal recessive type 29 genetic test at DNA Labs UAE is 4400 AED. This price may cover the cost of the sample collection, genetic analysis, and a comprehensive report detailing the findings. Such a test not only helps in confirming the diagnosis but also aids in family planning and understanding the risk of passing the condition to future generations.
